＜＜Back

Next＞＞

Vol. 26　No. 6　1998

* With abstract in English

Just before the kick-off of new GCP
－Performance of model hospitals for clinical trials under new GCP regulation－

New GCP Committee

---

<The application of ISO9000 to GCP>

GCP Group of Japan Society of Quality Assurance

51

Involvement of nerve growth factor in development of Hyperalgesia

T. Ishikawa

Jpn Pharmacol Ther 1998 26(6) 945-52*

---

Antigenicity study of CI-981

K. Matsuo, et al.

Jpn Pharmacol Ther 1998 26(6) 953-60*

---

Pharmacodynamic effects of CI-981

A. Shimada, et al.

Jpn Pharmacol Ther 1998 26(6) 961-80*

---

Combination effects of rabeprazole and teprenone on gastric mucosal lesion model induced by indometacin

M. Tanaka, et al.

Jpn Pharmacol Ther 1998 26(6) 981-7*

---

A comparative study of fibrin clot binding properties of E6010 with natural t-PA (tisokinase), recombinant t-PA (alteplase, EtPA) and urokinase

S. Kasai, et al.

Jpn Pharmacol Ther 1998 26(6) 989-92*

---

Effects of intravenous bolus injection of a novel thrombolytic drug, E6010, on improved prognosis in a canine model with laser ablation-induced coronary artery thrombi

S. Suzuki, et al.

Jpn Pharmacol Ther 1998 26(6) 993-1009*

Effects of calcium antagonists on blood pressure and plasma levels of lipid and superoxide and apo(lipo) proteins in high-aged hypertensive patients

K. Kondo, et al.

Jpn Pharmacol Ther 1998 26(6) 1011-8

---

Clinical effect of CN-SR in treatment of common cold syndrome

A. Urae, et al.

Jpn Pharmacol Ther 1998 26(6) 1019-26

---

Clinical evaluation of YO-106 (magnesium oxide tablets) in the treatment of habitual constipation
－A cross over study with magnesium oxide powders (JP)－

K. Sakimura

Jpn Pharmacol Ther 1998 26(6) 1027-53*

---

Safety of fasudil hydrochloride in combination with sodium ozagrel on cerebral vasospasm after aneurysmal subarachnoid hemorrhage

Y. Tanaka, et al.

Jpn Pharmacol Ther 1998 26(6) 1055-61